Moderna has asked Health Canada to approve its COVID-19 vaccine for children as young as six months old, a day after requesting U.S.
regulators do the same. If approved, it would be the first COVID-19 vaccine for children under five in Canada — an age group that has remained ineligible for inoculation since the vaccine rollout began in late 2020.
Moderna Canada submitted its vaccine candidate for children between six months and five years old for review on Thursday night, a spokesperson told Global News.
Health Canada updated its submission page on Friday, confirming its receipt. Read more: ‘Quebec won the battle:’ Moderna announces vaccine production plant for Montreal Moderna’s vaccine for children six to 11 was approved in March.